Dellegrottaglie Santo, Cospite Valentina, Pedrotti Patrizia, Pedretti Stefano, Lanzarin Barbara, Mauri Francesco, Roghi Alberto
Unità di Risonanza Magnetica Cardiaca, Dipartimento Cardiologico "A. De Gasperis", A.O. Niguarda Ca' Granda, Milano.
G Ital Cardiol (Rome). 2009 Feb;10(2):101-7.
Protocols of cardiac magnetic resonance imaging (CMR) during pharmacological stress with adenosine may include scanning sequences for the evaluation of both myocardial perfusion and contractility. The aim of this study was to define the feasibility and diagnostic accuracy of a stress CMR protocol including the combined evaluation of regional myocardial perfusion and contractility in the identification of patients with significant coronary artery disease.
A total of 184 consecutive patients with known or suspected coronary artery disease underwent stress CMR (adenosine, 140 microg/kg/min). The employed protocol included the application of the following sequences for image acquisition: 1) cine imaging at rest; 2) perfusion imaging (Gd-DTPA, 0.05 mmol/kg) during pharmacological stress; 3) cine imaging during pharmacological stress; 4) perfusion imaging (Gd-DTPA, 0.05 mmol/kg) at rest.
Stress CMR was completed in 182 patients (99%). Minor complications were observed in 12 patients (7%) during adenosine infusion, while one patient developed severe bronchospasm and another patient experienced persistent myocardial ischemia. Good/excellent-quality images were obtained in 91% of stress CMR exams. In a subgroup of 37 patients, when compared with the use of perfusion images alone, combination of perfusion and contractility data provided higher levels of sensitivity (74 vs 89%, p < 0.05) and of negative predictive value (71 vs 85%, p < 0.05) in identifying patients with significant coronary artery disease by invasive angiography.
Adenosine stress CMR including the evaluation of both myocardial perfusion and contractility is feasible and improves diagnostic performance in the recognition of patients with significant coronary artery disease.
腺苷药物负荷心脏磁共振成像(CMR)方案可能包括用于评估心肌灌注和收缩功能的扫描序列。本研究的目的是确定一种负荷CMR方案在识别严重冠状动脉疾病患者方面的可行性和诊断准确性,该方案包括对局部心肌灌注和收缩功能的联合评估。
共有184例已知或疑似冠状动脉疾病的连续患者接受了负荷CMR(腺苷,140μg/kg/min)检查。所采用的方案包括应用以下序列进行图像采集:1)静息电影成像;2)药物负荷期间的灌注成像(钆喷酸葡胺,0.05mmol/kg);3)药物负荷期间的电影成像;4)静息时的灌注成像(钆喷酸葡胺,0.05mmol/kg)。
182例患者(99%)完成了负荷CMR检查。在腺苷输注期间,12例患者(7%)出现轻微并发症,1例患者发生严重支气管痉挛,另1例患者出现持续性心肌缺血。91%的负荷CMR检查获得了良好/优秀质量的图像。在37例患者的亚组中,与单独使用灌注图像相比,灌注和收缩功能数据的联合在通过有创血管造影识别严重冠状动脉疾病患者时提供了更高水平的敏感性(74%对89%,p<0.05)和阴性预测值(71%对85%,p<0.05)。
包括心肌灌注和收缩功能评估的腺苷负荷CMR是可行的,并且在识别严重冠状动脉疾病患者方面提高了诊断性能。